Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:EEXNASDAQ:NEONASDAQ:NRDSNASDAQ:PHLT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEEXEmerald$4.69-3.9%$4.26$3.22▼$6.74$932.65M1.11195,774 shs108,718 shsNEONeoGenomics$7.07-4.3%$8.22$6.08▼$19.12$909.87M1.651.21 million shs1.53 million shsNRDSNerdWallet$10.96+2.0%$9.88$7.55▼$16.45$816.66M1.46558,636 shs744,146 shsPHLTPerformant Healthcare, Inc. - Common Stock$3.25-0.9%$2.65$2.17▼$4.35$254.50M0.3156,246 shs197,466 shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEEXEmerald-0.31%+5.13%+4.74%+19.50%-21.86%NEONeoGenomics-5.62%+3.65%-11.60%-24.75%-47.44%NRDSNerdWallet-1.65%-1.10%-7.49%+19.20%-21.09%PHLTPerformant Healthcare, Inc. - Common Stock+1.86%+9.33%+27.13%+13.10%+327,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEEXEmerald1.2965 of 5 stars3.51.00.80.01.50.00.0NEONeoGenomics3.8231 of 5 stars4.25.00.00.01.33.30.6NRDSNerdWallet2.8573 of 5 stars3.31.00.00.03.21.71.9PHLTPerformant Healthcare, Inc. - Common StockN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEEXEmerald 3.00Buy$7.9068.44% UpsideNEONeoGenomics 2.45Hold$13.8395.66% UpsideNRDSNerdWallet 2.67Moderate Buy$15.0036.86% UpsidePHLTPerformant Healthcare, Inc. - Common Stock 4.00Strong BuyN/AN/ACurrent Analyst Ratings BreakdownLatest PHLT, NEO, EEX, and NRDS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2025NEONeoGenomicsGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral5/6/2025NEONeoGenomicsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOverweight ➝ Overweight$18.00 ➝ $12.005/5/2025NRDSNerdWalletKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$18.00 ➝ $14.005/2/2025EEXEmeraldRosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$7.80 ➝ $7.805/1/2025NEONeoGenomicsMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$17.00 ➝ $10.004/30/2025NEONeoGenomicsLeerink PartnrsSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold4/30/2025NEONeoGenomicsThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$15.00 ➝ $10.004/30/2025NEONeoGenomicsLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market Perform$25.00 ➝ $9.004/29/2025NEONeoGenomicsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$18.00 ➝ $8.504/29/2025NRDSNerdWalletCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$14.00 ➝ $11.004/17/2025NEONeoGenomicsThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$17.00 ➝ $15.00(Data available from 6/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEEXEmerald$413.10M2.26$0.69 per share6.83($1.47) per share-3.19NEONeoGenomics$672.36M1.35$0.26 per share27.03$7.02 per share1.01NRDSNerdWallet$734.90M1.11$0.54 per share20.42$4.96 per share2.21PHLTPerformant Healthcare, Inc. - Common Stock$128.92M1.97N/AN/A$1.05 per share3.10Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEEXEmerald-$8.20M$0.03N/A∞N/A-5.29%-13.26%-1.92%8/6/2025 (Estimated)NEONeoGenomics-$87.97M-$0.61N/A78.56N/A-11.92%-2.10%-1.17%8/4/2025 (Estimated)NRDSNerdWallet-$11.80M$0.3927.4016.61N/A4.42%-2.08%-1.73%7/30/2025 (Estimated)PHLTPerformant Healthcare, Inc. - Common Stock-$7.52M-$0.08N/AN/AN/A-6.74%-10.19%-7.83%8/6/2025 (Estimated)Latest PHLT, NEO, EEX, and NRDS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025PHLTPerformant Healthcare, Inc. - Common Stock-$0.02$0.02+$0.04N/A$29.92 million$33.27 million5/1/2025Q1 2025EEXEmerald$0.07$0.08+$0.01$0.08$134.30 million$147.70 million4/29/2025Q1 2025NEONeoGenomics-$0.02-$0.08-$0.06-$0.20$171.38 million$168.04 million3/14/2025Q4 2024EEXEmerald$0.03$0.03N/A$0.03$108.05 million$106.80 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEEXEmerald$0.061.28%N/A200.00%N/ANEONeoGenomicsN/AN/AN/AN/AN/ANRDSNerdWalletN/AN/AN/AN/AN/APHLTPerformant Healthcare, Inc. - Common StockN/AN/AN/AN/AN/ALatest PHLT, NEO, EEX, and NRDS DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/2/2025EEXEmeraldquarterly$0.01501.3%5/12/20255/12/20255/22/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEEXEmerald1.021.271.27NEONeoGenomics0.381.981.91NRDSNerdWalletN/A3.272.91PHLTPerformant Healthcare, Inc. - Common Stock0.112.672.67Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEEXEmerald14.90%NEONeoGenomics98.50%NRDSNerdWallet38.81%PHLTPerformant Healthcare, Inc. - Common Stock77.15%Insider OwnershipCompanyInsider OwnershipEEXEmerald4.00%NEONeoGenomics2.40%NRDSNerdWallet46.54%PHLTPerformant Healthcare, Inc. - Common Stock9.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEEXEmerald600198.86 million179.64 millionOptionableNEONeoGenomics2,100128.70 million126.79 millionOptionableNRDSNerdWallet77074.51 million39.71 millionOptionablePHLTPerformant Healthcare, Inc. - Common Stock93078.31 million71.09 millionN/APHLT, NEO, EEX, and NRDS HeadlinesRecent News About These CompaniesPHLT Performant Healthcare, Inc.June 7, 2025 | seekingalpha.comPerformant Healthcare, Inc. - Common Stock (NASDAQ:PHLT) Trading 3.7% Higher - Here's What HappenedJune 7, 2025 | marketbeat.comLisa Im Sells 180,867 Shares of Performant Healthcare, Inc. - Common Stock (NASDAQ:PHLT) StockJune 5, 2025 | marketbeat.comPerformant Healthcare, Inc. - Common Stock (NASDAQ:PHLT) Director Lisa Im Sells 180,867 SharesJune 5, 2025 | insidertrades.comPerformant Healthcare, Inc. (PHLT) Q1 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comPerformant Healthcare: Q1 Earnings SnapshotMay 10, 2025 | timesunion.comPerformant Healthcare, Inc. Announces Financial Results for First Quarter 2025May 8, 2025 | businesswire.comPerformant Healthcare, Inc. to Report First Quarter 2025 Earnings on May 8, 2025April 24, 2025 | businesswire.comPerformant Survey Spotlights Top Healthcare Technology InitiativesApril 17, 2025 | businesswire.comPerformant Healthcare: Decent Quarter And Guidance But Valuation Remains A Concern - HoldMarch 17, 2025 | seekingalpha.comPerformant Healthcare, Inc. (PHLT) Q4 2024 Earnings Call TranscriptMarch 12, 2025 | seekingalpha.comPerformant Healthcare, Inc. Announces Financial Results for Fourth Quarter and Full Year 2024March 12, 2025 | businesswire.comPerformant to Participate in Upcoming March Investor ConferencesMarch 6, 2025 | businesswire.comPerformant Healthcare Announces Confirmation of RAC Opportunity With New York StateFebruary 27, 2025 | businesswire.comPerformant Healthcare, Inc. to Report Fourth Quarter 2024 Earnings on March 12, 2025February 26, 2025 | businesswire.comPerformant to Participate in the Upcoming Oppenheimer Emerging Growth ConferenceFebruary 19, 2025 | businesswire.comPerformant Achieves CMMI MATURITY Level 3, Demonstrating Commitment to Excellence and Continuous ImprovementFebruary 13, 2025 | businesswire.comPerformant to Participate in the Upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceFebruary 5, 2025 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePHLT, NEO, EEX, and NRDS Company DescriptionsEmerald NYSE:EEX$4.69 -0.19 (-3.89%) Closing price 03:59 PM EasternExtended Trading$4.68 -0.01 (-0.21%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Emerald Holding, Inc. operates business-to-business (B2B) trade shows in the United States. The company provides B2B trade show franchises; and B2B print publications and digital media products, which provide industry specific business news and information across various sectors. It also offers B2B e-commerce and digital merchandising solutions to manufacturers and retailers through Elastic Suite and Bulletin platforms. The company serves retail, design, technology, equipment, and safety and security. Emerald Holding, Inc. was incorporated in 2013 and is headquartered in New York, New York.NeoGenomics NASDAQ:NEO$7.07 -0.32 (-4.33%) Closing price 04:00 PM EasternExtended Trading$7.06 0.00 (-0.07%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.NerdWallet NASDAQ:NRDS$10.96 +0.22 (+2.05%) Closing price 04:00 PM EasternExtended Trading$10.95 -0.01 (-0.05%) As of 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NerdWallet, Inc. operates a digital platform that provides consumer-driven advice about personal finance by connecting individuals and small and mid-sized businesses with financial products providers in the United States, the United Kingdom, Australia, and Canada. Its platform offers guidance to consumers through educational content, tools and calculators, and product marketplaces, as well as through NerdWallet app for various financial products, including credit cards, mortgages, insurance, SMB products, personal loans, banking, investing, and student loans. The company was founded in 2009 and is based in San Francisco, California.Performant Healthcare, Inc. - Common Stock NASDAQ:PHLT$3.25 -0.03 (-0.91%) As of 04:00 PM EasternPerformant Healthcare, Inc. engages in the provision of technology-enabled audit, recovery, customer care, and related analytics services. Its services help identify improper payments, and in some markets, restructure and recover delinquent or defaulted assets and improper payments for both government and private clients. The company was founded in 1976 and is headquartered in Plantation, FL. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Fastenal Stock After Split: Poised for 5 More Years of Gains Analysts Love Lovesac, But Investors Should Be Cautious Oracle’s Cloud Boom Is Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
